CEO of Biotech Lobbying Group on Leave Amid Clash Over Direction
Dr. Michelle McMurry-Heath is on leave amid dissent within BIO, the industry’s top Washington lobbying group, about its direction and concern about its results, according to people familiar with the group.
Dr. Michelle McMurry-Heath is on leave amid dissent within BIO, the industry’s top Washington lobbying group, about its direction and concern about its results, according to people familiar with the group.
This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UR5RNKTDGRISFINFG7CZ7P4POY.jpg){kind=small}
